Literatur
Isenberg D, Appel GB, Contreras G et al (2010) Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology 49:128–140
Chan TM, Li FK, Tang CS et al (2000) Hong Kong-Guangzhou Nephrology Study Group. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343:1156–1162
Ginzler EM, Dooley MA, Aranow C et al (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353:2219–2228
Sinclair A, Appel G, Solomons N et al (2007) Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS). Lupus 16:972
Appel GB, Contreras G, Dooley MA et al (2009) Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 20:1103–1112
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thürmel, K. Induktionstherapie bei Lupusnephritis. Nephrologe 5, 150–151 (2010). https://doi.org/10.1007/s11560-010-0403-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11560-010-0403-8